血小板功能检测在神经外科止血功能评估中的现状与意义

doi:10.3969/j.issn.1673-5765.2024.07.017

摘要/Abstract

摘要：

随着人口老龄化，长期接受抗血小板治疗的患者在神经外科手术治疗人群中的比例不断增加。抗血小板药物导致的潜在血小板功能低下会影响术中止血效果，并增加术中大出血和术后出血并发症风险。因此，如何在术前快速准确地评估血小板功能，对于全面评估患者止血功能具有重要意义。本文通过总结相关文献，结合血小板功能检测在神经外科的使用现状，分析目前常用血小板功能检测方法的优缺点，介绍改善血小板功能的相关疗法，以期提高神经外科医师对血小板功能的认识。

文章导读： 血小板功能检测手段及改善疗法目前仍不完善，需要进行更多研究。

关键词: 血小板功能检测; 抗血小板治疗; 止血; 神经外科

Abstract: With the aging of the population, the proportion of patients receiving long-term antiplatelet therapy among those undergoing surgical treatment is increasing. Potential platelet hypofunction caused by antiplatelet drugs can affect intraoperative hemostasis and increase the risks of massive intraoperative hemorrhage and postoperative bleeding complications. Therefore, a quick and accurate assessment of platelet function before surgery is of great significance in comprehensively evaluating a patient’s hemostatic function. Based on the summary of relevant literature and the current status of the application of platelet function tests in neurosurgery, this paper analyzed the advantages and disadvantages of the currently commonly used platelet function tests, and introduced relevant therapies to improve platelet function, with the aim of improving the understanding of platelet function among neurosurgeons.

Key words: Platelet function test; Antiplatelet therapy; Hemostasis; Neurosurgery

中图分类号:

郭帅炜, 张亚南, 王硕.

血小板功能检测在神经外科止血功能评估中的现状与意义 [J]. 中国卒中杂志, 2024, 19(7): 848-853.

GUO Shuaiwei, ZHANG Ya’nan, WANG Shuo.

The Status and Significance of Platelet Function Tests in the Assessment of Hemostatic Function in Neurosurgery [J]. Chinese Journal of Stroke, 2024, 19(7): 848-853.

参考文献

[1] 中华医学会神经外科学分会. 神经外科围手术期出血防治专家共识（2018）[J]. 中华医学杂志，2018，98（7）：483-495.

Chinese Neurosurgical Society. Expert consensus on prevention and treatment of perioperative bleeding in neurosurgery（2018）[J]. Natl Med J China，2018，98（7）：483-495.

[2] CHEN Y P，LI L M，ZHANG Q L，et al. Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China：China Kadoorie biobank study of 0.5 million people[J]. Int J Cardiol，2014，172（1）：88-95.

[3] 王拥军，李子孝，谷鸿秋，等. 中国卒中报告2020（中文版）（2）[J]. 中国卒中杂志，2022，17（6）：553-567.

WANG Y J，LI Z X，GU H Q，et al. China stroke statistics 2020（2）[J]. Chin J Stroke，2022，17（6）：553-567.

[4] YEUNG J，LI W J，HOLINSTAT M. Platelet signaling and disease：targeted therapy for thrombosis and other related diseases[J]. Pharmacol Rev，2018，70（3）：526-548.

[5] VAN DER MEIJDEN P E J，HEEMSKERK J W M. Platelet biology and functions：new concepts and clinical perspectives[J]. Nat Rev Cardiol，2019，16（3）：166-179.

[6] HUANG J S，LI X，SHI X F，et al. Platelet integrin αⅡbβ3：signal transduction，regulation，and its therapeutic targeting[J/OL]. J Hematol Oncol，2019，12（1）：26[2023-05-20]. https://doi.org/10.1186/s13045-019-0709-6.

[7] DAI S H，HUA Y，KEEP R F，et al. Minocycline attenuates brain injury and iron overload after intracerebral hemorrhage in aged female rats[J/OL]. Neurobiol Dis，2019，126：76-84[2023-05-20]. https://doi.org/10.1016/j.nbd.2018.06.001.

[8] 彭斌. 联合抗血小板药物在缺血性脑卒中二级预防中的应用[J]. 中华脑血管病杂志（电子版），2020，14（1）：21-24.

PENG B. Dual antiplatelet therapy in secondary ischemic stroke prevention[J]. Chin J Cerebrovasc Dis（Electronic Edition），2020，14（1）：21-24.

[9] 刘晓丽，彭萍安，程宇婧. 血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）[J]. 心肺血管病杂志，2016，35（12）：923-932.

LIU X L，PENG P A，CHENG Y J. Chinese expert consensus on the platelet glycoprotein Ⅱb/Ⅲa receptor antagonists in the treatment of coronary atherosclerotic heart disease（2016）[J]. Journal of Cardiovascular ＆ Pulmonary Diseases，2016，35（12）：923-932.

[10] VINHOLT P J. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease[J]. Clin Chem Lab Med，2019，57（12）：1808-1817.

[11] BUGAEV N，COMO J J，GOLANI G，et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy：practice management guideline from the Eastern Association for the Surgery of Trauma[J]. J Trauma Acute Care Surg，2020，89（6）：999-1017.

[12] FARAONI D，DINARDO J A. Viscoelastic hemostatic assays：update on technology and clinical applications[J]. Am J Hematol，2021，96（10）：1331-1337.

[13] BARYSHNIKOVA E，DI DEDDA U，RANUCCI M. Comparative study of SEER sonorheometry versus standard coagulation tests，rotational thromboelastometry，and multiple electrode aggregometry in cardiac surgery[J]. J Cardiothorac Vasc Anesth，2019，33（6）：1590-1598.

[14] FOLKERSON L E，SLOAN D，COTTON B A，et al. Predicting progressive hemorrhagic injury from isolated traumatic brain injury and coagulation[J]. Surgery，2015，158（3）：655-661.

[15] AGARWAL S，COAKLEY M，REDDY K，et al. Quantifying the effect of antiplatelet therapy：a comparison of the platelet function analyzer（PFA-100）and modified thromboelastography（mTEG）with light transmission platelet aggregometry[J]. Anesthesiology，2006，105（4）：676-683.

[16] XIANG Q，WANG Z，ZHANG H X，et al. Predicting ischaemic events using platelet reactivity in patients receiving clopidogrel：indirect meta-comparison among VerifyNow，light transmission aggregometry and thromboelastography[J]. Basic Clin Pharmacol Toxicol，2020，127（4）：309-319.

[17] SUGAWARA E，SHIMIZU M，YAMAMOTO M，et al. Influence of platelet aggregate formation in blood samples on light transmission aggregometry results[J]. J Stroke Cerebrovasc Dis，2019，28（4）：1001-1006.

[18] LE BLANC J，MULLIER F，VAYNE C，et al. Advances in platelet function testing-light transmission aggregometry and beyond[J/OL]. J Clin Med，2020，9（8）：2636[2023-05-20]. https://doi.org/10.3390/jcm9082636.

[19] MA L，CHEN W Q，PAN Y S，et al. Comparison of VerifyNow，thromboelastography，and PL-12 in patients with minor ischemic stroke or transient ischemic attack[J]. Aging（Albany NY），2021，13（6）：8396-8407.

[20] PANICCIA R，ANTONUCCI E，GORI A M，et al. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment[J]. Am J Clin Pathol，2007，128（1）：143-149.

[21] GROVE E L，HVAS A M，JOHNSEN H L，et al. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease[J]. Thromb Haemost，2010，103（6）：1245-1253.

[22] ANGIOLILLO D J，BEEN L，RUBINSTEIN M，et al. Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor[J]. J Thromb Thrombolysis，2021，51（3）：741-747.

[23] ZHANG Y J，FAN D S，QIAO S D，et al. VerifyNow P2Y12 PRU-guided modification of clopidogrel for prevention of recurrent ischemic stroke：a real-world prospective cohort study[J]. Neurol Ther，2022，11（4）：1749-1766.

[24] SLICHTER S J，KAUFMAN R M，ASSMANN S F，et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage[J]. N Engl J Med，2010，362（7）：600-613.

[25] YAW H P，VAN DEN HELM S，LINDEN M，et al. Whole blood flow cytometry protocol for the assessment of platelet phenotype，function，and cellular interactions[J]. Platelets，2021，32（6）：786-793.

[26] 张学英，李玲玲，韩志勇. 冰冻血小板与新鲜血小板的疗效比较[J]. 临床和实验医学杂志，2013，12（1）：26-27.

ZHANG X Y，LI L L，HAN Z Y. A comparative study on curative effect of transfusion of freezing platelets and fresh apheresis platelets[J]. Journal of Clinical and Experimental Medicine，2013，12（1）：26-27.

[27] BAHAROGLU M I，CORDONNIER C，AL-SHAHI SALMAN R，et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy（PATCH）：a randomised，open-label，phase 3 trial[J]. Lancet，2016，387（10038）：2605-2613.

[28] 中华医学会神经外科学分会，中国医师协会急诊医师分会，国家卫生健康委员会脑卒中筛查与防治工程委员会. 出凝血功能障碍相关性脑出血中国多学科诊治指南[J]. 中华神经外科杂志，2021，37（7）：649-662.

Chinese Neurosurgical Society; Emergency Medicial Branch of Chinese Medical Doctor Association; Stroke Screening and Prevention Project Committee，National Health Commission. Chinese multidisciplinary guidelines for the diagnosis and treatment of hemostatic disorders associated intracerebral hemorrhage[J]. Chin J Neurosurg，2021，37（7）：649-662.

[29] KAUFMANN J E，VISCHER U M. Cellular mechanisms of the hemostatic effects of desmopressin（DDAVP）[J]. J Thromb Haemost，2003，1（4）：682-689.

[30] CALMER S，FERKAU A，LARMANN J，et al. Desmopressin（DDAVP）improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro[J]. Platelets，2014，25（1）：8-15.

[31] CASTRILLO A，CARDOSO M，ROUSE L. Treatment of buffy coat platelets in platelet additive solution with the mirasol® pathogen reduction technology system[J]. Transfus Med Hemother，2013，40（1）：44-48.

[32] ORSINI S，NORIS P，BURY L，et al. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders[J]. Haematologica，2017，102（7）：1192-1203.

[33] FRONTERA J A，LEWIN J J，3rd，RABINSTEIN A A，et al. Guideline for reversal of antithrombotics in intracranial hemorrhage：executive summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine[J]. Crit Care Med，2016，44（12）：2251-2257.